| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 05/24/2011 | US7947729 Adduct of fluorescent dye and tumor avid tetrapyrrole |
| 05/24/2011 | US7947709 Non-nucleoside reverse transcriptase inhibitors |
| 05/24/2011 | US7947697 8-(3-pentylamino)-2-methyl-3-(2-chloro-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d] pyrazolo[1,5-a]pyrimidine methanesulfonate as a CRF antagonist |
| 05/24/2011 | US7947695 5-membered annelated heterocyclic pyrimidines as kinase inhibitors |
| 05/24/2011 | US7947694 Substituted pyrazolo[3,4-D]pyrimidines as cell cycle kinase inhibitors |
| 05/24/2011 | US7947693 5,7-disubstituted thiazolo[4,5-D]pyrimidines as chemokine inhibitors |
| 05/24/2011 | US7947692 Substituted thiazolo[5,4-d]pyrimidine urea derivatives |
| 05/24/2011 | US7947690 Insulin secretagogue and hypoglycemic agent; pyrimidine derivatives condensed with a non-aromatic ring selected from dihydrothiophene, dihydrofuran, cycloalkane moiety; 1-[2-(4-chloro-2,5-difluorophenyl)-6,6-dioxido-5,7-dihydrothieno[3,4-d]pyrimidin-4-yl]-4-(3-hydroxypropyl)piperidin-4-ol for example |
| 05/24/2011 | US7947689 Substituted pyrazolo[1,5-a]pyrimidines as metabotropic glutamate receptor modulators |
| 05/24/2011 | US7947688 N-[3-(3-substituted-pyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-sulfonamides, and compositions, and methods related thereto |
| 05/24/2011 | US7947682 Substituted N′-pyrrolo[1,2-a]quinoxalin-4-yl-hydrazides as anti-cancer agents |
| 05/24/2011 | US7947678 Heterocyclic benzodiazepine CGRP receptor antagonists |
| 05/24/2011 | US7947676 Pyrazolo[3,4-d]pyrimidine compounds as antitumor agents |
| 05/24/2011 | US7947674 Meso-substituted porphyrins |
| 05/24/2011 | US7947672 Water-soluble anionic bacteriochlorophyll derivatives and their uses |
| 05/24/2011 | CA2645967C Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 05/24/2011 | CA2490888C Diaminopyrimidinecarboxamide derivative |
| 05/24/2011 | CA2472821C Process for producing fused imidazole compound, and reformatsky reagent in stable form and process for producing the same |
| 05/24/2011 | CA2342064C Long wave length absorbing bacteriochlorin alkyl ether analogs |
| 05/24/2011 | CA2341507C Porphyrin derivatives, their use in photodynamic therapy and medical devices containing them |
| 05/19/2011 | WO2011060112A1 Deuterated tyrosine kinase inhibitors |
| 05/19/2011 | WO2011059887A1 Hepatitis c virus inhibitors |
| 05/19/2011 | WO2011059839A1 Bicyclic pyridines and analogs as sirtuin modulators |
| 05/19/2011 | WO2011059463A1 Deuterated compounds for electronic applications |
| 05/19/2011 | WO2011058766A1 Aryl carboxamide derivatives as ttx-s blockers |
| 05/19/2011 | WO2011058582A1 Histone deacetylase inhibitors for the treatment of fungal infections |
| 05/19/2011 | WO2011058478A1 Substituted triazolopyrimidines as pde8 inhibitors |
| 05/19/2011 | WO2011058113A1 Fused bicyclic pyridine and pyrazine derivatives as kinase inhibitors |
| 05/19/2011 | WO2011058112A1 Fused bicyclic pyrazole derivatives as kinase inhibitors |
| 05/19/2011 | WO2011058110A1 Quinoline and quinoxaline derivatives as kinase inhibitors |
| 05/19/2011 | WO2011058109A1 Fused bicyclic pyrrole and imidazole derivatives as kinase inhibitors |
| 05/19/2011 | WO2011058108A1 Quinoline and quinoxaline derivatives as kinase inhibitors |
| 05/19/2011 | WO2011058025A1 N-7 substituted purine and pyrazolopyrimidine compounds, compositions and methods of use |
| 05/19/2011 | WO2011057590A1 New macrocyclic derivatives of glycolurils, and methods of preparing and using the same |
| 05/19/2011 | WO2011029775A8 [1,2,4]triazolo [1,5-c]pyrimidine derivatives as hsp90 modulators |
| 05/19/2011 | WO2011017342A3 Mesoionic pesticides |
| 05/19/2011 | WO2011003065A3 Pyrazolopyrimidine jak inhibitor compounds and methods |
| 05/19/2011 | WO2010151740A4 Polycyclic derivatives of pyridine and their use in the treatment of (inter alia) rheumatoid arthritis and similar diseases |
| 05/19/2011 | US20110118470 Nitrogen-containing aromatic derivatives |
| 05/19/2011 | US20110118303 Novel compounds derived from taurine, process of their preparation and pharmaceutical compositions containing these |
| 05/19/2011 | US20110118286 Bicyclic heterocycle derivatives and their use as gpcr modulators |
| 05/19/2011 | US20110118273 Pyrrolo-pyridine, pyrrolo-pyrimidine and related heterocyclic compounds |
| 05/19/2011 | US20110118269 Fused pyrazine compounds as their salts, useful for the treatment of degenerative and inflammatory diseases |
| 05/19/2011 | US20110118268 Novel 1,4-diaza-bicyclo[3.2.1]octane derivatives useful as nicotinic acetylcholine receptor modulators |
| 05/19/2011 | US20110118257 Novel kinase modulators |
| 05/19/2011 | US20110118255 PYRAZOLO[1,5-a]PYRIMIDINES USEFUL AS JAK2 INHIBITORS |
| 05/19/2011 | US20110118237 Isoxazoline linked pyrrolo[2,1-c][1,4]benzodiazepine hybrids as potential anticancer agents and the process for preparation thereof |
| 05/19/2011 | US20110118236 Heterocyclic compound |
| 05/19/2011 | US20110118231 Modulators of 5-ht receptors and methods of use thereof |
| 05/19/2011 | US20110118230 Diazacarbazoles and methods of use |
| 05/19/2011 | US20110118221 1,4-diaryl-pyrimidopyridazine-2,5-diones and their use |
| 05/19/2011 | US20110117651 Cell adhesion promoting agent and method of promoting cell adhesion |
| 05/19/2011 | US20110117081 Functionalized pyrrolidines and use thereof as iap inhibitors |
| 05/19/2011 | US20110117073 Protein Kinase Conjugates and Inhibitors |
| 05/19/2011 | US20110117029 Water-soluble anionic bacteriochlorophyll derivatives and their uses |
| 05/19/2011 | CA2781056A1 Kinase inhibitors |
| 05/19/2011 | CA2780547A1 Spiro-oxindole mdm2 antagonists |
| 05/19/2011 | CA2780018A1 N-7 substituted purine and pyrazolopyrimidine compounds, compositions and methods of use |
| 05/19/2011 | CA2779303A1 Bicyclic pyridines and analogs as sirtuin modulators |
| 05/18/2011 | EP2322528A1 Stemonamide synthesis intermediate and pharmaceutical composition for prevention and/or treatment of cancer |
| 05/18/2011 | EP2322527A1 Triazole derivatives |
| 05/18/2011 | EP2322526A1 Crystalline form of pemetrexed diacid and process for the preparation thereof |
| 05/18/2011 | EP2322521A1 Heteroaryl compounds useful as inhibitors of GSK-3 |
| 05/18/2011 | EP2322513A2 Intermediates |
| 05/18/2011 | EP2322173A1 Cationic bacteriochlorophyll derivatives and uses thereof |
| 05/18/2011 | EP2321321A1 Triazolo [4, 5-d]pyramidine derivatives and their use as purine receptor antagonists |
| 05/18/2011 | EP2321320A1 Novel compounds and their uses in diagnosis |
| 05/18/2011 | EP2321299A2 Pyridons as pdk1 inhibitors |
| 05/18/2011 | EP2321295A2 4-(pyridin-4-yl)-1h-[1,3,5]triazin-2-one derivatives as gsk3-beta inhibitors for the treatment of neurodegenerative diseases |
| 05/18/2011 | EP2320895A2 Cdk modulators |
| 05/18/2011 | EP1919920B1 Pentacyclic kinase inhibitors |
| 05/18/2011 | EP1861404B1 Polymorphic form of 6- (4-chlorophenyl) -2, 2-dimethyl-7-phenyl-2, 3-dihydro-lh-pyrrolizin-5-ylacetic acid |
| 05/18/2011 | EP1581221B1 Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonists |
| 05/18/2011 | CN1727340B Temozolomide 8-carboxylic ester, and combination |
| 05/18/2011 | CN102066554A Cell adhesion promoting agent and method of promoting cell adhesion |
| 05/18/2011 | CN102066380A Phenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as BACE-1 inhibitors, compositions, and their use |
| 05/18/2011 | CN102066379A Imidazo [2,1-b] quinazolin-2-one derivatives and their use as platelet anti-aggregative agents |
| 05/18/2011 | CN102066378A 3-(3-pyrimidin-2-yl-benzyl)-[1,2,4]triazolo[4,3-b]pyridazine derivatives as MET kinase inhibitors |
| 05/18/2011 | CN102066377A Novel phenylimidazopyrazines |
| 05/18/2011 | CN102066376A Anhydrous crystal form of orvepitant maleate |
| 05/18/2011 | CN102066370A Novel phenyl-imidazopyridines and pyridazines |
| 05/18/2011 | CN102066322A Compound having NPY Y5 receptor antagonist activity |
| 05/18/2011 | CN102066320A Aryl ketone as MRI |
| 05/18/2011 | CN102060858A Method for simultaneously extracting chlorophyll and protein from red clover processing waste water |
| 05/18/2011 | CN102060857A Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 05/18/2011 | CN102058603A Disubstituted zinc phthalocyanine composite, and preparation method and application thereof |
| 05/18/2011 | CN101497616B Imidazopyridine compound containing aminoxy substituted pyridine |
| 05/18/2011 | CN101357922B New DPP-IV inhibitor |
| 05/18/2011 | CN101289450B Tyrosine phthalocyanines derivates, preparation thereof and applications in preparation of photodynamic drugs |
| 05/18/2011 | CN101120000B Pyrazolopyrimidines |
| 05/17/2011 | US7943788 Glucopyranoside compound |
| 05/17/2011 | US7943771 Reacting 4-chloro-1-isobutyl-1H-imidazo[4,5-c]-quinoline with non-gaseous amine precursor of guanidine or salt, urea, melamine, semicarbazide or salt, a carbamate, 3-amino-1,2,4-triazine, 3-amino-1,2,4-triazole, or 4-amino-1,2,4-triazole in solvent; amination, purification; chemical intermediates |
| 05/17/2011 | US7943770 Fused quinoline derivative and use thereof |
| 05/17/2011 | US7943767 Fused bicyclic mTOR inhibitors |
| 05/17/2011 | US7943654 1H-thieno[2,3-c]pyrazole compounds useful as kinase inhibitors |
| 05/17/2011 | US7943652 Hydroxamate-based inhibitors of deacetylases B |
| 05/17/2011 | US7943635 Farnesyl-protein transferase inhibitors |
| 05/17/2011 | US7943624 Pyridinylpyrazolopyrimidinone derivatives as PDE 7 inhibitors |
| 05/17/2011 | US7943617 Heterobicyclic compounds useful as kinase inhibitors |
| 05/17/2011 | US7943616 Protein kinase inhibitors; astham; psoriasis; antiinflammatory agents; inflammatory bowel disorders |